Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer

Trial Profile

Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer

Recruiting
Phase of Trial: Phase 0

Latest Information Update: 28 May 2018

At a glance

  • Drugs Oxycodone (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Acronyms RAD 1702
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 18 May 2018 Status changed from not yet recruiting to recruiting.
    • 13 Feb 2018 Planned initiation date changed from 1 Jan 2018 to 1 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top